Browse regulations

Federal regulation requiring drug-free workplace policies for recipients of Department of Labor grants and financial assistance awards, including employee notification requirements, workplace identification, and penalties for violations including debarment

Creates massive bureaucratic compliance costs and liability risks for grant recipients while having no measurable impact on drug use rates. The administrative burden disproportionately harms small organizations and nonprofits, and the threat of debarment for workplace violations creates chilling effects on legitimate activities. State and local governments already have drug laws - federal duplication serves no purpose beyond expanding bureaucratic control over private organizations.

Part 902 establishes the dispute resolution process for the Compact Council, created under the National Crime Prevention and Privacy Compact. It defines cognizable disputes (misinterpretation of Compact, exceeding authority, procedural violations, or non-compliance by a Party), identifies who may raise disputes (Party States, FBI, or directly aggrieved parties), outlines the Dispute Resolution Committee process, prescribes hearing procedures (public hearings, right to present evidence, cross-examine, record minutes), and provides for appeals to the Attorney General and then to federal court.

Deleting this regulation would eliminate the only formal mechanism for challenging the Compact Council's actions, creating a due process vacuum. Without prescribed procedures, disputes would be resolved arbitrarily, undermining accountability and the rule of law. The modest administrative costs are justified by ensuring that interpretations of the Compact are subject to review, preventing unchecked bureaucratic power and protecting the rights of states and individuals affected by Council decisions.

CSOSA's FOIA/Privacy Act procedural regulations detail request submission, processing timelines, exemptions, appeals, fees, and business submitter protections for this specific agency.

Duplicates statutory FOIA requirements, adding to the $2 trillion regulatory burden and 185,000-page CFR complexity; imposes significant administrative costs on the agency and taxpayers without enhancing transparency. Simpler, non-binding guidance would achieve the same objectives at far lower cost, reducing bureaucratic delays and hidden taxes on Americans.

Aviation security regulation requiring providers to submit flight training candidates (especially foreign nationals) for background checks by the Attorney General before training on aircraft over 12,500 lbs, with 45-day review periods and fingerprint requirements.

Creates massive compliance costs for flight schools, discourages legitimate foreign aviation training, and imposes federal overreach on what should be state-regulated education/training activities. The unseen costs include reduced aviation workforce development and economic protectionism for domestic pilots.

Regulation implements the Drug-Free Workplace Act for DOJ grants and cooperative agreements, requiring recipients to establish drug-free workplace policies, report employee drug convictions within 10 days, take corrective action within 30 days, and identify all workplaces covered. Violations can result in suspension, termination, or debarment from federal awards for up to five years.

Imposes substantial compliance costs on small grantees and nonprofits, diverting resources from their core missions. Condition on federal funds coerces adoption of a uniform federal workplace standard, encroaching on state and private authority over employment policies. Concentrates waiver power solely with the Attorney General, inviting arbitrary discretion. The regulation's contribution to the $2 trillion annual compliance burden outweighs its speculative benefits in preventing misuse of grant funds.

Federal regulation mandates DNA collection from incarcerated/convicted individuals and those arrested for qualifying offenses, requires FBI analysis and entry into CODIS, and mandates preservation of biological evidence for imprisoned defendants. Covers broad range of offenses including many non-felonies.

Massive costs exceeding any proven benefit; creates permanent genetic database without consent violating bodily integrity and privacy; mission creep from violent felons to minor offenses; enforcement risks including errors and misuse; federal overreach imposing unfunded mandates on state/local agencies. The unseen costs of normalizing government DNA collection far outweigh uncertain crime-solving benefits.

DOJ regulation implementing 42 U.S.C. 233(i) to remove Public Health Service employee status from high-risk healthcare providers, stripping them of FTCA immunity. Establishes detailed administrative process: notice, ALJ hearings, discovery, burden of proof, and 5-year reconsideration petitions.

Compliance imposes multi-agency administrative burden costing millions annually, with no clear offsetting benefit beyond government risk management that could be achieved more simply. Unseen effects: discourages healthcare providers from serving in federal programs and free clinics, reducing access in underserved areas; creates complex regulatory maze that small entities cannot navigate, protecting incumbents; violates rule of law through 185,000+ pages of nuanced procedures that no one can fully comprehend. The process is precisely the type of bureaucratic mission creep that expands liability rather than resolves it.

Regulation establishes conditions under which TTB accepts electronic signatures and electronic form submissions as alternatives to traditional handwritten signatures and paper forms. It defines electronic signatures, digital signatures, and biometrics; sets security requirements for signature systems (two-factor authentication for non-biometric, owner-only access for biometric); outlines procedures for electronic form submission through designated systems; and maintains that electronic signatures have the same legal effect as handwritten signatures. Participation is voluntary—it permits but does not require electronic submission.

Americans would be worse off without this regulation because it would eliminate a less burdensome, modern compliance pathway, forcing businesses to continue costly paper-based submissions, increasing time, postage, and administrative overhead unnecessarily. The regulation achieves its goal of secure electronic authentication through well-established technical and procedural standards that are proven effective and widely adopted across government and industry; removing it would not improve security but would raise compliance costs and reduce efficiency.

This regulation establishes OIG's policies for responding to subpoenas, demands, and requests for official records, information, or testimony from OIG employees in legal proceedings where HUD or OIG is not a named party. It requires written requests with specific information, authorizes the Counsel to approve or deny such requests based on multiple factors including burden, confidentiality, and ongoing investigations, and allows OIG to impose conditions or fees for compliance.

This regulation creates unnecessary bureaucratic barriers to legitimate legal discovery, potentially shielding wrongdoing from public scrutiny. The extensive discretionary approval process and fee structure could be used to delay or deny access to information that should be publicly available through FOIA. The sovereign immunity language and procedural hurdles protect OIG from accountability rather than serving taxpayers.

Federal regulation governing public housing homeownership programs that allow PHAs to sell public housing units to low-income families or purchase-and-resale entities (PREs) for resale, with requirements for eligibility, financing, property standards, and recapture of appreciation.

This regulation creates a complex bureaucratic system that distorts housing markets, imposes costly compliance requirements on PHAs, and uses taxpayer funds to subsidize homeownership that could be achieved through private markets. The recapture provisions and extensive restrictions on resale create artificial barriers to property transfer and reduce housing supply flexibility.

This regulation implements 23 U.S.C. 163, using federal highway funding as leverage to force states to adopt 0.08 blood alcohol concentration per se laws. It provides incentive grants for compliance and withholds 2-8% of highway funds from non-complying states, with a detailed certification and enforcement regime.

This regulation violates constitutional federalism by coercing state legislatures through funding threats. It establishes a de facto national criminal law standard without congressional legislation, distorting state policy priorities and undermining political competition among states. The unseen costs include federalized lawmaking that eliminates laboratory-of-experiments benefits and prevents states from setting thresholds appropriate to their unique demographics and cultures.

This regulation implements the Drug-Free Workplace Act of 1988 for grants and cooperative agreements from the African Development Foundation, requiring recipients to maintain drug-free workplaces through published statements, awareness programs, employee reporting requirements, and personnel actions for violations, with enforcement mechanisms including suspension, termination, and debarment.

This regulation represents federal overreach into workplace governance that should be left to states and private employers. The compliance costs and administrative burden fall disproportionately on small grant recipients, creating barriers to participation in federal programs. Workplace drug policies are better determined by individual organizations based on their specific needs and local conditions, not by one-size-fits-all federal mandates that have shown minimal effectiveness in reducing drug use while imposing significant regulatory costs.

This regulation implements the government-wide debarment and suspension system for the African Development Foundation's nonprocurement transactions. It establishes procedures to exclude persons who are not 'responsible' from participating in federal assistance programs, defines covered transactions, requires checks of the Excluded Parties List System (EPLS), and sets forth suspension and debarment processes with reciprocal effect across federal agencies.

Repealing this would allow individuals and entities convicted of fraud, embezzlement, or other serious offenses to access federal funds, directly harming taxpayers. The system is narrowly applied only to those with criminal convictions or civil judgments for program-related misconduct, includes due process protections (notice and opportunity to respond), and is essential for deterring waste, fraud, and abuse in federal programs. The modest administrative burden of checking a centralized database is far outweighed by the billions in potential losses prevented.

This regulation implements the Drug-Free Workplace Act for Inter-American Foundation grant recipients, requiring them to publish drug-free workplace statements, establish awareness programs, report employee drug convictions within 10 days, and take personnel action or require rehabilitation. It applies to grants/cooperative agreements but not procurement contracts.

Federal micromanagement of private workplace policies through conditional funding violates Tenth Amendment principles and creates disproportionate compliance burdens on small organizations. The regulation expands federal surveillance via mandatory conviction reporting, distorts hiring by penalizing past drug offenses, and imposes a hidden tax exceeding the benefits of federally dictating employment conditions that should be determined by employers and states. The knowledge problem prevents Washington from designing optimal workplace policies for thousands of diverse recipients.

This regulation implements the Drug-Free Workplace Act of 1988 for Peace Corps grants, requiring recipients to maintain drug-free workplaces through employee notification, awareness programs, workplace identification, and penalties for violations including debarment for up to five years.

Federal drug-free workplace mandates represent costly regulatory overreach that imposes compliance burdens on small grant recipients while achieving minimal public benefit. The regulation creates a complex administrative framework for monitoring employee drug use that properly belongs to state and local jurisdictions, diverts resources from program objectives, and enables bureaucratic expansion through debarment powers. Private employers already have strong incentives to maintain productive workplaces without federal coercion.